Skip to main content

Table 1 COPD patients and control subjects in the study

From: Altered fibroblast proteoglycan production in COPD

Characteristics

Controls

 

COPD

 

   No.

12

 

8

 

   Age (range)

30

(24--41)

62

(53--66)

   Pack years (range)

0

 

41

(25--60)

   Gender, M/F in %

42/58

 

37/63

 

Lung function

    

   FEV1

4.0

(3.0--5.4)

0.57

(0.4--0.9)

   FEV1 % predicted

106.7

(95--116)

19.7

(14--24)

   FVC

4.8

(3.5--6.4)

2.0

(1.3--2.8)

   FEV1 % predicted/FVC

22

(17--28)

31

(20--39)

   DLCO

m

 

1.4

(1.4--1.5)†

   DLCO % predicted

m

 

24

(14--42)§

  1. † Only values from 4 patients. § Only values from 5 patients. m denotes that data is missing
  2. Data is presented as mean (range)
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us